{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T14:02:52Z","timestamp":1722780172597},"reference-count":91,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0087342","type":"journal-article","created":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T22:03:02Z","timestamp":1391551382000},"page":"e87342","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Species D Human Adenovirus Type 9 Exhibits Better Virus-Spread Ability for Antitumor Efficacy among Alternative Serotypes"],"prefix":"10.1371","volume":"9","author":[{"given":"Junji","family":"Uchino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.","family":"Curiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyo","family":"Ugai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"ref1","first-page":"10","article-title":"Cancer statistics, 2012","volume":"62","author":"R Siegel","year":"2012","journal-title":"CA: a cancer journal for clinicians"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"DX Nguyen","year":"2009","journal-title":"Nature reviews Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/35101008","article-title":"Cancer gene therapy: fringe or cutting edge","volume":"1","author":"F McCormick","year":"2001","journal-title":"Nature reviews Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nrc948","article-title":"Oncolytic viruses","volume":"2","author":"EA Chiocca","year":"2002","journal-title":"Nature reviews Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.tips.2007.05.005","article-title":"Viruses as anticancer drugs","volume":"28","author":"SJ Russell","year":"2007","journal-title":"Trends in pharmacological sciences"},{"key":"ref6","first-page":"3395","article-title":"The development of conditionally replicative adenoviruses for cancer therapy","volume":"6","author":"DT Curiel","year":"2000","journal-title":"Clinical cancer research"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/77283","article-title":"Replicative adenoviruses for cancer therapy","volume":"18","author":"R Alemany","year":"2000","journal-title":"Nature biotechnology"},{"key":"ref8","unstructured":"Shenk TE (2001) Adenoviridae: the viruses and their replication; Knipe DM, Howley PM, editors. Philadelphia: Lippincott Williams & Wilkins. 1053\u20131088 p."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1566523044577997","article-title":"Transductional and transcriptional targeting of adenovirus for clinical applications","volume":"4","author":"JN Glasgow","year":"2004","journal-title":"Current gene therapy"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.virol.2012.05.028","article-title":"Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1","volume":"432","author":"H Ugai","year":"2012","journal-title":"Virology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.amjsurg.2007.04.014","article-title":"Optimization of conditionally replicative adenovirus for pancreatic cancer and its evaluation in an orthotopic murine xenograft model","volume":"195","author":"PJ Ramirez","year":"2008","journal-title":"Am J Surg"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"SJ Russell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/cgt.2009.5","article-title":"An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector","volume":"16","author":"DL Lichtenstein","year":"2009","journal-title":"Cancer gene therapy"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e2409","DOI":"10.1371\/journal.pone.0002409","article-title":"Directed evolution generates a novel oncolytic virus for the treatment of colon cancer","volume":"3","author":"I Kuhn","year":"2008","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Kim KH, Dmitriev IP, Saddekni S, Kashentseva EA, Harris RD, et al. (2013) A phase I clinical trial of Ad5\/3-Delta24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer. Gynecol Oncol.","DOI":"10.1016\/j.ygyno.2013.06.003"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/gt.2008.179","article-title":"A phase I trial of intratumoral administration of recombinant oncolytic adenovirus overexpressing HSP70 in advanced solid tumor patients","volume":"16","author":"JL Li","year":"2009","journal-title":"Gene Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1158\/1078-0432.CCR-09-3167","article-title":"Oncolytic adenovirus ICOVIR-7 in patients with advanced and refractory solid tumors","volume":"16","author":"P Nokisalmi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/mt.2010.161","article-title":"Treatment of cancer patients with a serotype 5\/3 chimeric oncolytic adenovirus expressing GMCSF","volume":"18","author":"A Koski","year":"2010","journal-title":"Mol Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1158\/0008-5472.CAN-09-3567","article-title":"Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients","volume":"70","author":"V Cerullo","year":"2010","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/mt.2009.262","article-title":"A phase I study of telomerase-specific replication competent oncolytic adenovirus (telomelysin) for various solid tumors","volume":"18","author":"J Nemunaitis","year":"2010","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref21","first-page":"4968","article-title":"Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer","volume":"62","author":"SO Freytag","year":"2002","journal-title":"Cancer research"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1158\/1078-0432.CCR-10-0791","article-title":"A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases","volume":"16","author":"KJ Kimball","year":"2010","journal-title":"Clinical cancer research"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1158\/1078-0432.CCR-05-1059","article-title":"CG0070, a conditionally replicating granulocyte macrophage colony-stimulating factor\u2013armed oncolytic adenovirus for the treatment of bladder cancer","volume":"12","author":"N Ramesh","year":"2006","journal-title":"Clinical cancer research"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.gt.3301377","article-title":"Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned","volume":"8","author":"D Kirn","year":"2001","journal-title":"Gene therapy"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1089\/104303401750270977","article-title":"Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved\u2013deletion of the viral E1b-19-kD gene increases the viral oncolytic effect","volume":"12","author":"D Harrison","year":"2001","journal-title":"Human Gene Therapy"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/104303403321467199","article-title":"Intratumoral spread of wild-type adenovirus is limited after local injection of human xenograft tumors: virus persists and spreads systemically at late time points","volume":"14","author":"H Sauthoff","year":"2003","journal-title":"Human Gene Therapy"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/sj.mt.6300239","article-title":"Systemic toxicity-efficacy profile of ICOVIR-5, a potent and selective oncolytic adenovirus based on the pRB pathway","volume":"15","author":"M Cascallo","year":"2007","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/10430340050015851","article-title":"Deletion of the adenoviral E1b-19kD gene enhances tumor cell killing of a replicating adenoviral vector","volume":"11","author":"H Sauthoff","year":"2000","journal-title":"Human Gene Therapy"},{"key":"ref29","first-page":"7882","article-title":"A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging","volume":"61","author":"Y Adachi","year":"2001","journal-title":"Cancer research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1006\/mthe.2001.0275","article-title":"Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers","volume":"3","author":"M Yamamoto","year":"2001","journal-title":"Molecular therapy: the journal of the American Society of Gene Therapy"},{"key":"ref31","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"TL DeWeese","year":"2001","journal-title":"Cancer research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.cgt.7700928","article-title":"Transductional targeting of adenovirus vectors for gene therapy","volume":"13","author":"JN Glasgow","year":"2006","journal-title":"Cancer gene therapy"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-12-398342-8.00002-1","article-title":"Chapter two\u2013Adenovirus strategies for tissue-specific targeting","volume":"115","author":"MS Beatty","year":"2012","journal-title":"Advances in cancer research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/cgt.2011.47","article-title":"Mining the adenovirus virome for oncolytics against multiple solid tumor types","volume":"18","author":"CY Chen","year":"2011","journal-title":"Cancer gene therapy"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1128\/JVI.80.4.2000-2012.2006","article-title":"Genetic identification of adenovirus type 5 genes that influence viral spread","volume":"80","author":"T Subramanian","year":"2006","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1128\/JVI.77.4.2640-2650.2003","article-title":"Developing novel oncolytic adenoviruses through bioselection","volume":"77","author":"W Yan","year":"2003","journal-title":"J Virol"},{"key":"ref37","unstructured":"Fields BN, Knipe DM, Howley PM (2007) Fields virology. Philadelphia: Wolters Kluwer Health\/Lippincott Williams & Wilkins."},{"key":"ref38","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/0042-6822(67)90241-3","article-title":"Biochemical studies on adenovirus multiplication. XII. Plaquing efficiencies of purified human adenoviruses","volume":"31","author":"M Green","year":"1967","journal-title":"Virology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"JM Bergelson","year":"1997","journal-title":"Science"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7883\/yoken1952.47.157","article-title":"A simple and efficient method for purification of infectious recombinant adenovirus","volume":"47","author":"Y Kanegae","year":"1994","journal-title":"Japanese journal of medical science & biology"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0006-291X(02)02852-8","article-title":"Spontaneous mutations in the human gene for p53 in recombinant adenovirus during multiple passages in human embryonic kidney 293 cells","volume":"300","author":"H Ugai","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref42","first-page":"115","article-title":"The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"JV Maizel Jr","year":"1968","journal-title":"Virology"},{"key":"ref43","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning, a laboratory manual. NY: Cold Spring Harbor Laboratory Press."},{"key":"ref44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jmb.2009.10.034","article-title":"In vitro dynamic visualization analysis of fluorescently labeled minor capsid protein IX and core protein V by simultaneous detection","volume":"395","author":"H Ugai","year":"2010","journal-title":"J Mol Biol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1128\/JVI.70.10.6839-6846.1996","article-title":"Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism","volume":"70","author":"VN Krasnykh","year":"1996","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1128\/JVI.54.3.711-719.1985","article-title":"Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome","volume":"54","author":"I Saito","year":"1985","journal-title":"J Virol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/JVI.62.5.1647-1652.1988","article-title":"A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses","volume":"62","author":"KH Hsu","year":"1988","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1038\/sj.bjc.6600932","article-title":"The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells","volume":"88","author":"M Kim","year":"2003","journal-title":"Br J Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/pros.21070","article-title":"Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells","volume":"70","author":"M Murakami","year":"2010","journal-title":"The Prostate"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"A Gros","year":"2008","journal-title":"Cancer research"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jmb.2006.11.090","article-title":"Thermostability\/infectivity defect caused by deletion of the core protein V gene in human adenovirus type 5 is rescued by thermo-selectable mutations in the core protein X precursor","volume":"366","author":"H Ugai","year":"2007","journal-title":"J Mol Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/rmv.612","article-title":"Adenovirus receptors: implications for tropism, treatment and targeting","volume":"19","author":"N Arnberg","year":"2009","journal-title":"Reviews in medical virology"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"12125","DOI":"10.1128\/JVI.79.19.12125-12131.2005","article-title":"Adenovirus receptors","volume":"79","author":"Y Zhang","year":"2005","journal-title":"J Virol"},{"key":"ref54","first-page":"7909","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol","volume":"72","author":"PW Roelvink","year":"1998"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1128\/JVI.75.15.7210-7214.2001","article-title":"Adenovirus type 9 fiber knob binds to the coxsackie B virus-adenovirus receptor (CAR) with lower affinity than fiber knobs of other CAR-binding adenovirus serotypes","volume":"75","author":"I Kirby","year":"2001","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1128\/JVI.70.11.7614-7621.1996","article-title":"Comparative analysis of adenovirus fiber-cell interaction: adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment","volume":"70","author":"PW Roelvink","year":"1996","journal-title":"J Virol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"e8526","DOI":"10.1371\/journal.pone.0008526","article-title":"Derivation of a triple mosaic adenovirus for cancer gene therapy","volume":"4","author":"Y Tang","year":"2009","journal-title":"PLoS One"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/JVI.62.5.1647-1652.1988","article-title":"A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses","volume":"62","author":"KH Hsu","year":"1988","journal-title":"J Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1128\/JVI.76.9.4612-4620.2002","article-title":"Exploiting the natural diversity in adenovirus tropism for therapy and prevention of disease","volume":"76","author":"MJ Havenga","year":"2002","journal-title":"J Virol"},{"key":"ref60","first-page":"745","article-title":"Structural proteins of adenoviruses. 8. Characterization of incomplete particles of adenovirus type 3","volume":"49","author":"L Prage","year":"1972","journal-title":"Virology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1128\/JVI.68.2.1239-1244.1994","article-title":"Adenovirus type 40 and 41 growth in vitro: host range diversity reflected by differences in patterns of DNA replication","volume":"68","author":"CT Tiemessen","year":"1994","journal-title":"J Virol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00705-010-0683-3","article-title":"Development of a method for effective amplification of human adenovirus 40","volume":"155","author":"S Yamasaki","year":"2010","journal-title":"Arch Virol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"R Vogels","year":"2003","journal-title":"J Virol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1128\/JVI.02407-10","article-title":"Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge","volume":"85","author":"TW Geisbert","year":"2011","journal-title":"J Virol"},{"key":"ref65","first-page":"4654","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol","volume":"81","author":"P Abbink","year":"2007"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1749-6632.1957.tb46055.x","article-title":"Clinical associations of enteric viruses with particular reference to agents exhibiting properties of the ECHO group","volume":"67","author":"S Kibrick","year":"1957","journal-title":"Ann N Y Acad Sci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1128\/JCM.37.12.3940-3945.1999","article-title":"Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively","volume":"37","author":"JC De Jong","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.meegid.2009.02.001","article-title":"Molecular epidemiology of adenovirus infection among infants and children with acute gastroenteritis in Dhaka City, Bangladesh","volume":"9","author":"SK Dey","year":"2009","journal-title":"Infect Genet Evol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"e33212","DOI":"10.1371\/journal.pone.0033212","article-title":"Computational and serologic analysis of novel and known viruses in species human adenovirus D in which serology and genomics do not correlate","volume":"7","author":"EB Liu","year":"2012","journal-title":"PLoS One"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/infdis\/148.1.24","article-title":"The changing etiology of epidemic keratoconjunctivitis: antigenic and restriction enzyme analyses of adenovirus types 19 and 37 isolated over a 10-year period","volume":"148","author":"MC Kemp","year":"1983","journal-title":"The Journal of infectious diseases"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/oxfordjournals.epirev.a036304","article-title":"Epidemiology of epidemic keratoconjunctivitis","volume":"9","author":"E Ford","year":"1987","journal-title":"Epidemiologic reviews"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.2002.1404","article-title":"The novel early region 3 protein E3\/49K is specifically expressed by adenoviruses of subgenus D: implications for epidemic keratoconjunctivitis and adenovirus evolution","volume":"296","author":"JH Blusch","year":"2002","journal-title":"Virology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/CMR.5.3.262","article-title":"Adenoviruses in the immunocompromised host","volume":"5","author":"JC Hierholzer","year":"1992","journal-title":"Clin Microbiol Rev"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/infdis\/172.3.629","article-title":"Adenovirus infections in human immunodeficiency virus-positive patients: clinical features and molecular epidemiology","volume":"172","author":"SH Khoo","year":"1995","journal-title":"J Infect Dis"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1128\/JCM.37.12.3940-3945.1999","article-title":"Adenoviruses from human immunodeficiency virus-infected individuals, including two strains that represent new candidate serotypes Ad50 and Ad51 of species B1 and D, respectively","volume":"37","author":"JC De Jong","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JVI.74.1.42-48.2000","article-title":"Adenovirus type 37 uses sialic acid as a cellular receptor","volume":"74","author":"N Arnberg","year":"2000","journal-title":"J Virol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"7691","DOI":"10.1128\/JVI.74.16.7691-7693.2000","article-title":"Initial interactions of subgenus D adenoviruses with A549 cellular receptors: sialic acid versus alpha(v) integrins","volume":"74","author":"N Arnberg","year":"2000","journal-title":"J Virol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1006\/viro.2002.1503","article-title":"Adenovirus type 37 binds to cell surface sialic acid through a charge-dependent interaction","volume":"302","author":"N Arnberg","year":"2002","journal-title":"Virology"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"A Gaggar","year":"2003","journal-title":"Nature medicine"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3171\/jns.2000.92.6.1002","article-title":"Dependence of efficient adenoviral gene delivery in malignant glioma cells on the expression levels of the Coxsackievirus and adenovirus receptor","volume":"92","author":"K Asaoka","year":"2000","journal-title":"Journal of neurosurgery"},{"key":"ref81","first-page":"325","article-title":"Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy","volume":"59","author":"Y Li","year":"1999","journal-title":"Cancer research"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0090-4295(02)01748-X","article-title":"Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer","volume":"60","author":"MD Sachs","year":"2002","journal-title":"Urology"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/sj.bjc.6604876","article-title":"Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression","volume":"100","author":"M Anders","year":"2009","journal-title":"Br J Cancer"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-008-0108-0","article-title":"Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer","volume":"116","author":"D Auer","year":"2009","journal-title":"Breast cancer research and treatment"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.cgt.7700947","article-title":"Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation","volume":"13","author":"WM Korn","year":"2006","journal-title":"Cancer gene therapy"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urology.2005.02.033","article-title":"Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer","volume":"66","author":"K Matsumoto","year":"2005","journal-title":"Urology"},{"key":"ref87","first-page":"6592","article-title":"The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure","volume":"61","author":"T Okegawa","year":"2001","journal-title":"Cancer research"},{"key":"ref88","first-page":"3812","article-title":"Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy","volume":"62","author":"KA Rauen","year":"2002","journal-title":"Cancer research"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.gt.3301775","article-title":"Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas","volume":"9","author":"AG Zeimet","year":"2002","journal-title":"Gene therapy"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"SN Waddington","year":"2008","journal-title":"Cell"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1073\/pnas.0711757105","article-title":"Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo","volume":"105","author":"O Kalyuzhniy","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0087342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T02:08:02Z","timestamp":1597457282000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0087342"}},"subtitle":[],"editor":[{"given":"Joseph Charles","family":"Glorioso","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":91,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0087342","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}